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1). At a mean follow-up of 2.3 +/- 2.8 months,
rates of all-cause mortality (OR: 0.70, 95% CI
= 0.56 – 0.88), major bleeding (OR: 0.58, 95%
CI = 0.44 – 0.76) and vascular complications
(OR: 0.38, 95% CI = 0.28 – 0.51) were lower
in TRA as compared to TFA while there was

no difference in rates of MACE, MI and
stroke between groups.

major bleeding and vascular complications in
STEMI patients undergoing PCI. 

Conclusion: Our analysis shows that TRA is
associated with better long-term survival as
compared to TFA along with lower rates of

https://doi.org/10.32873/unmc.dc.gmerj.2.1.057

Figure 1. Forest plots showing outcomes with transradial and transfemoral approaches in STEMI.
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Background: A 21 year-old man presented
with a two-day history of left leg pain and
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swelling following recent admission for nontraumatic splenic rupture due to presumed
infectious mononucleosis. He had swelling,
tenderness and erythema of the left lower
extremity, primarily surrounding the calf.
Doppler ultrasound revealed non-occlusive
deep vein thrombosis (DTV) of the left

proximal femoral vein and he was started
on apixaban for anticoagulation. Laboratory
workup for clotting disorder revealed
heterozygous Factor V Leiden mutation.
One week later his leg pain and swelling
worsened. Repeat Doppler revealed extensive
progression of the DVT despite appropriate
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the clot and revealed extensive compression
of the proximal left common iliac vein by
the right common iliac artery suggestive of
May-Thurner syndrome. Intravenous heparin
anticoagulation was initiated and apixaban
held, but there was suspicion for development
of heparin induced thrombocytopenia
so he was transitioned to argatroban for
anticoagulation.
Methods: Physical Exam, Doppler
Ultrasound, CT Angiography

Conclusion: To manage May-Thurner
syndrome he underwent manual
thrombectomy with endovascular stent
placement. The following night he developed
worsening pain and swelling in his left leg
consistent with compartment syndrome. He
underwent four compartment fasciotomy
and was restarted on argatroban. Repeat
Doppler ultrasound revealed recurrence of
extensive left lower extremity DVT. Given
multiple recurrent DVTs despite adequate
anticoagulation, dedicated peripheral blood

smear was obtained and revealed atypical
myeloblasts concerning for acute myeloid
     
marrow biopsy, he was started on induction
chemotherapy. He remained in hospital
receiving ongoing chemotherapy after
residual disease was detected on bone
marrow biopsy following initial
chemotherapy cycles. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.059
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Background: A 27-year-old female with no
medical history presented with one month
of progressively worsening jaundice and
a 30-pound weight loss. She was found to
have conjugated hyperbilirubinemia with
an acute cholestatic hepatitis. Ultrasound of
the liver was unremarkable and magnetic
resonance cholangiopancreatography
revealed normal appearing intrahepatic and
extrahepatic bile ducts without mechanical
obstruction. An extensive workup for
autoimmune and infectious etiologies of
hepatitis was unremarkable. A liver biopsy
        
ductopenia suggestive of vanishing bile duct
syndrome (VBDS). A computed tomography
scan of the chest revealed a large complex
anterior mediastinal mass with extensive
lymphadenopathy (Figure 1). A core needle

biopsy of the right supraclavicular lymph
node was obtained, and pathology was
consistent with Hodgkin's lymphoma. She
was initiated on induction therapy with
improvement in her liver enzymes.

liver transplantation. Prognosis is variable
as some progress to cirrhosis and others
have regeneration of biliary epithelium with
recovery of hepatic function. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.061

Methods: Ultrasound, CT scan
Conclusion: VBDS refers to a group of
disorders with variable etiologies that cause
a progressive destruction of intrahepatic bile
ducts with resulting cholestatic liver injury.
The diagnosis is made pathologically and
requires a paucity of interlobular bile ducts,
        
a bile duct on biopsy. Etiologies include
infections, ischemia, autoimmune conditions,
drug reactions, and malignancy. Treatment
depends on the underlying cause and includes
withdrawal of offending medications,
immunosuppression, ursodeoxycholic acid,
and treatment of malignancy in patients with
paraneoplastic VBDS. Those with irreversible
hepatic failure should be considered for

Figure 1. Computed tomography scan of the
chest demonstrating large anterior mediastinal
mass.
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Background: A 39-year-old female presented
with sudden onset of abdominal pain and
hematochezia. Her medical history was
     
abdomen was tender to palpation in the left
lower quadrant without rigidity. Workup
       !
"  #   !
for gastrointestinal pathogens, including
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performed and revealed a diffusely edematous,
ulcerated and violaceous segment of the
sigmoid colon concerning for severe ischemic
injury (Figure 1). Biopsies of the mucosa
 &    
ischemic colitis. Review of medications was
    ! 
was discontinued due to suspicion for drug
induced colonic ischemia. The patient’s
hematochezia and abdominal pain resolved
with conservative treatment.
Methods: Physical Exam, Colonoscopy

Conclusion: When young adults present with
*&    & "
bowel disease, and hemorrhoids are
commonly considered. However, intestinal
ischemia is an important differential diagnosis.
Ischemic colitis is the most common form of
intestinal ischemia, generally encountered
in patients greater than 50 years old as
a result of nonocclusive hypoperfusion.
Rarely, ischemic colitis may result from
drug exposure. Mesenteric thrombotic
events linked to contraceptive medications
have been described in the literature and are
thought to be secondary to a hypercoagulable
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